Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

New study re MRSA in JAMA-Journal of American Medical Association.Attempt to decrease MRSA infection rates in a varrity of types of surgery involved-1 screen for nasal carriage 2 intranasal mupirocin and 3 Vancomycin plus a cephalosporin given at surgery

Admitttedly Vancomycin less of a hassle to give as a one time dose, but one can imagine Brilacidin working better(longer half life) and maybe finding a role in such situations. Remains to be seen.

MRSA rates with all 3 steps went from 36 to 21 per 10,000

Potentially a lot of doses of antibiotics use for B. Not to mention Brilacidin as potential competitor for Mupirocin(MRSA topical)

Have not read through whole article yet to hear about downsides, such as CDiff